Search clinical trials for: Placebo drinking solution

Total 69288 results

Boehringer Ingelheim

Completed

Safety and Tolerability of BI 638683 After Single Rising Oral Doses in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

Healthy

Germany
Charite University, Berlin, Germany
Wilhelm-Doerenkamp-Foundation (Funding)

Recruiting

Nutraceutical Improvement of Glucose Metabolism, NAFLD and Insulin Resistance by Oat-fiber Supplementation in Type 2 Diabetes Mellitus Patients (NIMROD)

Type 2 Diabetes | NAFLD

Germany
University of Ulster
Fundación Cántaro Azul, A.C. (NGO), Mexico; Centro de Ciencia y Tecnologia... and other collaborators

Enrolling by invitation

SAFEWATER Health & Behaviour Impact Field Trials; Mexico

Water-Related Diseases

Colombia, Mexico
University of Ulster
Fundación Cántaro Azul, A.C. (NGO), Mexico; Centro de Ciencia y Tecnologia... and other collaborators

Enrolling by invitation

SAFEWATER Health & Behaviour Impact Field Trials; Colombia (SAFEWATER)

Water-Related Diseases

Colombia, Mexico
pH Pharma

Completed

Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma

Normal Tension Glaucoma

Korea, Republic of
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

Infections, Respiratory Tract

United States
3E Therapeutics Corporation
ORA, Inc.

Completed

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

Seasonal Allergic Rhinitis
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Dry Eye With Sjögren's Syndrome

Japan
Kissei Pharmaceutical Co., Ltd.

Completed

A Late Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes

Dry Eye Syndromes

Japan
Crinetics Pharmaceuticals Inc.

Completed

A Single and Multiple-Ascending Dose Study of CRN01941 in Healthy Adult Volunteers

Healthy Volunteers

Australia
Virginia Polytechnic Institute and State University
Carilion Clinic; University at Buffalo

Recruiting

Episodic Future Thinking to Improve Management of Type 2 Diabetes: Remote Delivery and Outcomes Assessment

Type 2 Diabetes | Overweight and Obesity

United States
Mansoura University

Active, not recruiting

Different Surgical Drilling Protocols in Posterior Maxilla

Missing Teeth

Egypt
HanAll BioPharma Co., Ltd.
Daewoong Pharmaceutical Co. LTD.

Completed

A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes (VELOS-2)

Dry Eye

United States
Harbour BioMed (Guangzhou) Co. Ltd.

Completed

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Merck Sharp & Dohme LLC

Completed

Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma

Ocular Hypertension | Open Angle Glaucoma
University Hospital, Montpellier
AstraZeneca; Association Jean Baptiste Desbrest

Completed

Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma

Asthma

France
Association Jean Baptiste Desbrest
AstraZeneca; University Hospital, Montpellier

Unknown

Expert Statements Concerning the Tapering of Oral Corticosteroids (OCS) for the Treatment of Asthma

Asthma

France
Henry Ford Health System
Michigan State University; University of Kansas; University of Maryland, College...

Recruiting

Parent-Child Memory Study: Improving Future Thinking Among Mothers

Behavior, Health

United States
Aerie Pharmaceuticals

Completed

A Controlled Study of the Aqueous Humor Dynamics of AR-13324 Ophthalmic Solution in Healthy Adult Volunteers

Healthy Subjects

United States
INSYS Therapeutics Inc

Withdrawn

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome

Lennox-Gastaut Syndrome
Santen Pharmaceutical Co., Ltd.

Completed

A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
Catalysis SL

Completed

Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome

COVID-19 | Inflammation | Fatigue | Cough | Dyspnea | Post-COVID-19 Syndrome

Colombia
Tiziana Life Sciences LTD

Withdrawn

Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MS

Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis
University of Houston

Unknown

Effect of Ocular Hygiene on Scleral Lens Wear

Scleral Contact Lenses

United States
LEO Pharma

Completed

LEO 22811 - A Phase 1, Double-Blind, Placebo-controlled, Single and Multiple Oral Dose Study in Healthy Subjects

Psoriasis Vulgaris

United Kingdom
Laboratorios Sophia S.A de C.V.

Withdrawn

Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis (PRO-118)

Conjunctivitis, Allergic | Seasonal Allergic Conjunctivitis | Ocular Itching | Ocular Allergy | Perennial Allergic Conjunctivitis

Mexico
Encore Vision, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia

Presbyopia

United States
Istituto Ortopedico Rizzoli

Recruiting

Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis

Knee Osteoarthritis

Italy
University of Oxford
Novartis Pharmaceuticals; The TIMI Study Group

Active, not recruiting

A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease (ORION-4)

Atherosclerotic Cardiovascular Disease

United Kingdom, United States
The Medicines Company

Completed

Trial to Evaluate the Effect of Inclisiran Treatment on Low Density Lipoprotein Cholesterol (LDL-C) in Subjects With Heterozygous Familial Hypercholesterolemia (HeFH) (ORION-9)

Elevated Cholesterol | Heterozygous Familial Hypercholesterolemia

United States, Canada, Czechia, Denmark, Netherlands, South Africa, Spain, Sweden
ASIT Biotech S.A.

Completed

Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients

House Dust Mite Allergy

Germany
Bitop AG

Completed

Efficacy and Feasibility of Ectoin® Inhalation Solution in Inflammatory Obstruction and Ageing of the Lung (EFECT)

COPD | Particulate Matter Induced Inflammation of the Lung

Germany
University of Florida
United States Department of Defense; VA Office of Research and Development; University...

Completed

Effectiveness of a Driving Intervention on Safe Community Mobility for Returning Combat Veterans

Post Traumatic Stress Disorder (PTSD) | Traumatic Brain Injury (TBI)

United States
Boehringer Ingelheim

Completed

Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects

Healthy
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers

Healthy
Yuyu Pharma, Inc.

Active, not recruiting

Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1)

Dry Eye

United States
Fondazione G.B. Bietti, IRCCS
CNR Institute for chemical and physical processes (IPCF), Messina

Completed

Transepithelial Corneal Cross-linking Using Iontophoresis (T-iontoCL)

Progressive Keratoconus

Italy
Harbour BioMed (Guangzhou) Co. Ltd.

Recruiting

A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye

Dry Eye

China
Chakshu Research, Inc.

Unknown

Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract

Cataract

United States
Oregon Health and Science University
National Eye Institute (NEI)

Recruiting

Collagen Cross-linking in Keratoconus

Keratoconus

United States
Jerath U Nivedita

Completed

Driving Ability in Patients With CMT 1A

CMT 1A

United States
Galapagos NV

Completed

A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970

Healthy | Psoriasis

Belgium, Moldova, Republic of, Ukraine
INSYS Therapeutics Inc

Withdrawn

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome

Dravet Syndrome
Nielsen BioSciences, Inc.

Recruiting

Candin for the Treatment of Common Warts

Common Warts (Verruca Vulgaris)

United States
University of Leicester
GlaxoSmithKline

Active, not recruiting

Mepolizumab for COPD Hospital Eosinophilic Admissions Pragmatic Trial (COPD-HELP)

Eosinophilia | COPD

United Kingdom
AnaptysBio, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States, Canada, Georgia, Poland
Columbia University
NYU Langone Health; CSL Behring

Terminated

Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection

COVID-19

United States
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever

Spain, Belgium, Italy
Allakos Inc.

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001

Atopy

United States

3

Subscribe